These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8598505)

  • 1. Comparing the toxicity of two drugs in the framework of spontaneous reporting: a confidence interval approach.
    Tubert-Bitter P; Begaud B; Moride Y; Chaslerie A; Haramburu F
    J Clin Epidemiol; 1996 Jan; 49(1):121-3. PubMed ID: 8598505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area.
    Conforti A; Leone R; Moretti U; Mozzo F; Velo G
    Drug Saf; 2001; 24(14):1081-90. PubMed ID: 11735663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios.
    van der Heijden PG; van Puijenbroek EP; van Buuren S; van der Hofstede JW
    Stat Med; 2002 Jul; 21(14):2027-44. PubMed ID: 12111885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration.
    Hartnell NR; Wilson JP
    Pharmacotherapy; 2004 Jun; 24(6):743-9. PubMed ID: 15222664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations.
    Figueras A; Capellà D; Castel JM; Laorte JR
    Eur J Clin Pharmacol; 1994; 47(4):297-303. PubMed ID: 7875178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.
    Leone R; Conforti A; Venegoni M; Motola D; Moretti U; Meneghelli I; Cocci A; Sangiorgi Cellini G; Scotto S; Montanaro N; Velo G
    Drug Saf; 2005; 28(6):547-56. PubMed ID: 15924506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting.
    Tsong Y
    J Biopharm Stat; 1995 Mar; 5(1):95-114. PubMed ID: 7613562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006.
    Lapeyre-Mestre M; Grolleau S; Montastruc JL;
    Fundam Clin Pharmacol; 2013 Apr; 27(2):223-30. PubMed ID: 21929527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Organization and results of drug vigilance in France].
    Bégaud B; Chaslerie A; Haramburu F
    Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bias in spontaneous reporting of adverse drug reactions in Japan.
    Matsuda S; Aoki K; Kawamata T; Kimotsuki T; Kobayashi T; Kuriki H; Nakayama T; Okugawa S; Sugimura Y; Tomita M; Takahashi Y
    PLoS One; 2015; 10(5):e0126413. PubMed ID: 25933226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A statistical methodology for drug-drug interaction surveillance.
    Norén GN; Sundberg R; Bate A; Edwards IR
    Stat Med; 2008 Jul; 27(16):3057-70. PubMed ID: 18344185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.
    Rossi AC; Hsu JP; Faich GA
    Br Med J (Clin Res Ed); 1987 Jan; 294(6565):147-50. PubMed ID: 3109543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of spontaneous adverse drug reaction monitoring systems.
    Sachs RM; Bortnichak EA
    Am J Med; 1986 Nov; 81(5B):49-55. PubMed ID: 3789003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A distributed, collaborative intelligent agent system approach for proactive postmarketing drug safety surveillance.
    Ji Y; Ying H; Farber MS; Yen J; Dews P; Miller RE; Massanari RM
    IEEE Trans Inf Technol Biomed; 2010 May; 14(3):826-37. PubMed ID: 20007038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions related to the use of non-steroidal anti-inflammatory drugs: results of spontaneous reporting from central India.
    Shrivastava MP; Chaudhari HV; Dakhale GN; Hiware SK; Solanke BP; Shinde A
    J Indian Med Assoc; 2013 Feb; 111(2):99-102, 106. PubMed ID: 24003566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of preexisting health conditions on the outcome of an adverse drug reaction alerting program: gastrointestinal disorders before piroxicam and sulindac therapy.
    Rawson NS
    Ann Pharmacother; 1995; 29(7-8):676-80. PubMed ID: 8520079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.
    Passarelli MC; Jacob-Filho W; Figueras A
    Drugs Aging; 2005; 22(9):767-77. PubMed ID: 16156680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-positives in spontaneous reporting: should we worry about them?
    Begaud B; Moride Y; Tubert-Bitter P; Chaslerie A; Haramburu F
    Br J Clin Pharmacol; 1994 Nov; 38(5):401-4. PubMed ID: 7893579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions: a review of relevant factors.
    Ajayi FO; Sun H; Perry J
    J Clin Pharmacol; 2000 Oct; 40(10):1093-101. PubMed ID: 11028248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is reporting rate a good predictor of risks associated with drugs?
    Pierfitte C; Bégaud B; Lagnaoui R; Moore ND
    Br J Clin Pharmacol; 1999 Mar; 47(3):329-31. PubMed ID: 10215758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.